Literature DB >> 25205593

Amyloid-β efflux from the central nervous system into the plasma.

Kaleigh Filisa Roberts1, Donald L Elbert, Tom P Kasten, Bruce W Patterson, Wendy C Sigurdson, Rose E Connors, Vitaliy Ovod, Ling Y Munsell, Kwasi G Mawuenyega, Michelle M Miller-Thomas, Christopher J Moran, Dewitte T Cross, Colin P Derdeyn, Randall J Bateman.   

Abstract

OBJECTIVE: The aim of this study was to measure the flux of amyloid-β (Aβ) across the human cerebral capillary bed to determine whether transport into the blood is a significant mechanism of clearance for Aβ produced in the central nervous system (CNS).
METHODS: Time-matched blood samples were simultaneously collected from a cerebral vein (including the sigmoid sinus, inferior petrosal sinus, and the internal jugular vein), femoral vein, and radial artery of patients undergoing inferior petrosal sinus sampling. For each plasma sample, Aβ concentration was assessed by 3 assays, and the venous to arterial Aβ concentration ratios were determined.
RESULTS: Aβ concentration was increased by ∼7.5% in venous blood leaving the CNS capillary bed compared to arterial blood, indicating efflux from the CNS into the peripheral blood (p < 0.0001). There was no difference in peripheral venous Aβ concentration compared to arterial blood concentration.
INTERPRETATION: Our results are consistent with clearance of CNS-derived Aβ into the venous blood supply with no increase from a peripheral capillary bed. Modeling these results suggests that direct transport of Aβ across the blood-brain barrier accounts for ∼25% of Aβ clearance, and reabsorption of cerebrospinal fluid Aβ accounts for ∼25% of the total CNS Aβ clearance in humans. Ann Neurol 2014;76:837-844.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25205593      PMCID: PMC4355962          DOI: 10.1002/ana.24270

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

1.  Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Keely M Murphy; Liping Meng; Janitza Montalvo-Ortiz; Ziling Zeng; Benedict J Kolber; Shanshan Zhang; Louis J Muglia; John G Csernansky
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Ronald B DeMattos; Kelly R Bales; David J Cummins; Steven M Paul; David M Holtzman
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

3.  Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects.

Authors:  P T Fox; M E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

Authors:  Rashid Deane; Zhenhua Wu; Abhay Sagare; Judianne Davis; Shi Du Yan; Katie Hamm; Feng Xu; Margaret Parisi; Barbra LaRue; Hong Wei Hu; Patricia Spijkers; Huang Guo; Xiaomei Song; Peter J Lenting; William E Van Nostrand; Berislav V Zlokovic
Journal:  Neuron       Date:  2004-08-05       Impact factor: 17.173

Review 5.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

8.  Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study.

Authors:  O L Lopez; L H Kuller; P D Mehta; J T Becker; H M Gach; R A Sweet; Y F Chang; R Tracy; S T DeKosky
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

9.  Performance characteristics of plasma amyloid-beta 40 and 42 assays.

Authors:  Olivia I Okereke; Weiming Xia; Michael C Irizarry; Xiaoyan Sun; Wei Q Qiu; Anne M Fagan; Pankaj D Mehta; Bradley T Hyman; Dennis J Selkoe; Francine Grodstein
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers.

Authors:  Rachel Potter; Bruce W Patterson; Donald L Elbert; Vitaliy Ovod; Tom Kasten; Wendy Sigurdson; Kwasi Mawuenyega; Tyler Blazey; Alison Goate; Robert Chott; Kevin E Yarasheski; David M Holtzman; John C Morris; Tammie L S Benzinger; Randall J Bateman
Journal:  Sci Transl Med       Date:  2013-06-12       Impact factor: 17.956

View more
  83 in total

Review 1.  SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.

Authors:  Ross W Paterson; Audrey Gabelle; Brendan P Lucey; Nicolas R Barthélemy; Claire A Leckey; Christophe Hirtz; Sylvain Lehmann; Chihiro Sato; Bruce W Patterson; Tim West; Kevin Yarasheski; Jonathan D Rohrer; Norelle C Wildburger; Jonathan M Schott; Celeste M Karch; Selina Wray; Timothy M Miller; Donald L Elbert; Henrik Zetterberg; Nick C Fox; Randall J Bateman
Journal:  Nat Rev Neurol       Date:  2019-06-20       Impact factor: 42.937

Review 2.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

3.  Age and amyloid effects on human central nervous system amyloid-beta kinetics.

Authors:  Bruce W Patterson; Donald L Elbert; Kwasi G Mawuenyega; Tom Kasten; Vitaliy Ovod; Shengmei Ma; Chengjie Xiong; Robert Chott; Kevin Yarasheski; Wendy Sigurdson; Lily Zhang; Alison Goate; Tammie Benzinger; John C Morris; David Holtzman; Randall J Bateman
Journal:  Ann Neurol       Date:  2015-07-20       Impact factor: 10.422

4.  Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.

Authors:  Vitaliy Ovod; Kara N Ramsey; Kwasi G Mawuenyega; Jim G Bollinger; Terry Hicks; Theresa Schneider; Melissa Sullivan; Katrina Paumier; David M Holtzman; John C Morris; Tammie Benzinger; Anne M Fagan; Bruce W Patterson; Randall J Bateman
Journal:  Alzheimers Dement       Date:  2017-07-19       Impact factor: 21.566

Review 5.  Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.

Authors:  Hyung J Ahn; Zu-Lin Chen; Daria Zamolodchikov; Erin H Norris; Sidney Strickland
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

Review 6.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

7.  Treadmill Exercise Ameliorates Spatial Learning and Memory Deficits Through Improving the Clearance of Peripheral and Central Amyloid-Beta Levels.

Authors:  Davar Khodadadi; Reza Gharakhanlou; Naser Naghdi; Mona Salimi; Mohammad Azimi; Atabak Shahed; Soomaayeh Heysieattalab
Journal:  Neurochem Res       Date:  2018-06-11       Impact factor: 3.996

8.  Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.

Authors:  Ye-Ran Wang; Qing-Hua Wang; Tao Zhang; Yu-Hui Liu; Xiu-Qing Yao; Fan Zeng; Jing Li; Fa-Yin Zhou; Lin Wang; Jia-Chuan Yan; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.590

9.  Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.

Authors:  Steffen E Storck; Sabrina Meister; Julius Nahrath; Julius N Meißner; Nils Schubert; Alessandro Di Spiezio; Sandra Baches; Roosmarijn E Vandenbroucke; Yvonne Bouter; Ingrid Prikulis; Carsten Korth; Sascha Weggen; Axel Heimann; Markus Schwaninger; Thomas A Bayer; Claus U Pietrzik
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

Review 10.  Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Authors:  Kenzo Koizumi; Gang Wang; Laibaik Park
Journal:  Cell Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.